Apogee TherapeuticsAPGE
那斯達克 · USD
37.96
+0.60
(+1.61%)
盤中 08/15 01:15 (UTC+8)
08/15 01:15 (UTC+8)
Apogee TherapeuticsAPGE
37.96
+0.60
(+1.61%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 0 | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | - | - | - | - | - |
營業費用 | 73,165 | - | - | - | - | - | 37,155 | 24,305 | 18,885 | 12,658 |
研發費用 | 55,703 | 46,387 | 60,229 | 45,714 | 33,206 | 28,716 | 28,954 | 17,069 | 13,946 | 8,455 |
推銷及管理費用 | 17,137 | 16,709 | 15,652 | 12,972 | 10,916 | 9,465 | 8,201 | 7,236 | 4,939 | 4,203 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -73,165 | -63,096 | -75,881 | -58,686 | -44,122 | -38,181 | -37,155 | -24,305 | -18,885 | -12,658 |
其他收入及費用 | - | 7,840 | 8,681 | 9,668 | 10,306 | 6,087 | 5,420 | 3,465 | - | 133 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -66,024 | -55,256 | -67,200 | -49,018 | -33,816 | -32,094 | -31,735 | -20,840 | -18,885 | -12,525 |
所得稅 | 72 | 83 | 18 | - | - | - | - | - | - | - |
稅後純益 | -66,096 | -55,339 | -67,218 | -49,018 | -33,816 | -32,094 | -31,735 | -20,840 | -18,885 | -12,525 |
基本每股稅後盈餘(元) | -1.13 | -0.95 | -1.20 | -0.86 | -0.60 | -0.64 | - | -0.51 | -0.40 | -0.46 |
稀釋每股稅後盈餘(元) | -1.13 | -0.95 | -1.19 | -0.87 | -0.60 | -0.64 | -0.32 | 3.24 | -3.77 | -2.51 |
基本平均股數(千股) | 58428.00 | 58195.00 | 57276.00 | 56795.00 | 56515.00 | 50189.00 | - | 41231.00 | 47615.00 | 27246.00 |
稀釋平均股數(千股) | 58428.00 | 58195.00 | 57276.00 | 56795.00 | 56515.00 | 50189.00 | - | 41231.00 | 47615.00 | 27246.00 |
還原基本每股稅後盈餘(元) | -1.13 | -0.95 | -1.20 | -0.86 | -0.60 | -0.64 | - | -0.51 | -0.40 | -0.46 |
還原稀釋每股稅後盈餘(元) | -1.13 | -0.95 | -1.19 | -0.87 | -0.60 | -0.64 | -0.32 | 3.24 | -3.77 | -2.51 |
還原基本平均股數(千股) | 58,428 | 58,195 | 57,276 | 56,795 | 56,515 | 50,189 | - | 41,231 | 47,615 | 27,246 |
還原稀釋平均股數(千股) | 58,428 | 58,195 | 57,276 | 56,795 | 56,515 | 50,189 | - | 41,231 | 47,615 | 27,246 |
EBITDA(千元) | -65,625 | -57,428 | -70,110 | -52,475 | -36,820 | -34,775 | -34,574 | -21,072 | -18,885 | -12,525 |